Yeah, it rained last week in San Francisco. But the rain did not stop untold thousands of us from gathering at the many hotels, watering holes, and coffee shops around…
BIO Europe was, yet again, an excellent conference for Lacerta Bio. Having the US election on television screens in the Exhibition Hall made for some surreal moments and discussions. Not a…
A few weeks ago, we attended the first annual Commercializing Biotech Innovation Conference in Syracuse, New York. The conference was held in the very new Central New York Biotech Accelerator in Syracuse (which is…
Ample numbers of electrons will be spent discussing the BIO2016 conference in San Francisco last week, both positive and negative. Not wanting to be left out of the fun,…
Next week, our industry makes an unusual return trip to Union Square, as we return for another conference. This time, it's BIO. BIO is unlike other conferences on our circuit,…
How was Bio Europe in Stockholm last week? The Conference Itself – For us, the conference was terrific. We had nearly 30 high-quality meetings over the three days of partnering,…
Given that we are now in January, we feel obliged to craft some sort of "Predictions for 2016" post. We're not big fans of predictive posts, mainly because we're…
This morning, our friends at EBD and MacDougall Biomedical Communications presented a very good webinar on preparing for the upcoming festivities in San Francisco. In case you missed it, I…
I love what you did with the place... It's always difficult for us to contribute any sensible overarching overview of any partnering conference, especially BIO Europe Fall. This is entirely…
Last month, EBD and IMS partnered to analyze meeting outcomes from four conferences, covering nearly 5,000 participating companies. Their report is available here (PDF). As we are knee-deep in scheduling…